These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1205306)

  • 1. Proceedings: Abnormalities of splenic function in ulcerative colitis and Crohn's disease.
    Ryan FP; Preston FE; Smart RC; Holdsworth CD
    Gut; 1975 Oct; 16(10):834. PubMed ID: 1205306
    [No Abstract]   [Full Text] [Related]  

  • 2. Splenic phagocytic function in patients with inflammatory bowel disease.
    Jewell DP; Berney JJ; Pettit JE
    Pathology; 1981 Oct; 13(4):717-23. PubMed ID: 7335378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unfractioned heparin in the therapy of patients with highly active inflammatory bowel disease.
    Folwaczny C; Wiebecke B; Loeschke K
    Am J Gastroenterol; 1999 Jun; 94(6):1551-5. PubMed ID: 10364024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma levels of endothelin-1 in patients with Crohn's disease and ulcerative colitis.
    Letizia C; Boirivant M; De Toma G; Cerci S; Subioli S; Scuro L; Ferrari P; Pallone F
    Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):266-9. PubMed ID: 9759593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
    Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
    Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory mediators and acute phase proteins in patients with Crohn's disease and ulcerative colitis.
    Niederau C; Backmerhoff F; Schumacher B; Niederau C
    Hepatogastroenterology; 1997; 44(13):90-107. PubMed ID: 9058126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Splenic function in inflammatory bowel disease: assessment by differential interference microscopy and splenic ultrasound.
    Muller AF; Cornford E; Toghill PJ
    Q J Med; 1993 May; 86(5):333-40. PubMed ID: 8327651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Serum mucoproteins in patients with nonspecific ulcerative colitis and Crohn's disease].
    Levitan MKh; Dovgun LM; Ilysheva GN; Chernomordik AE; Ksenofontov BS
    Sov Med; 1980; (7):19-22. PubMed ID: 7256382
    [No Abstract]   [Full Text] [Related]  

  • 9. Tumor necrosis factor-alpha antagonism improves endothelial dysfunction in patients with Crohn's disease.
    Schinzari F; Armuzzi A; De Pascalis B; Mores N; Tesauro M; Melina D; Cardillo C
    Clin Pharmacol Ther; 2008 Jan; 83(1):70-6. PubMed ID: 17507924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum zinc and taste acuity in Tel-Aviv patients with inflammatory bowel disease.
    Tiomny E; Horwitz C; Graff E; Rozen P; Gilat T
    Am J Gastroenterol; 1982 Feb; 77(2):101-4. PubMed ID: 7072676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyposplenism in inflammatory bowel disease.
    Ryan FP; Smart RC; Holdsworth CD; Preston FE
    Gut; 1978 Jan; 19(1):50-5. PubMed ID: 624506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased number of steroid receptors of circulating lymphocytes in Crohn's disease and ulcerative colitis.
    Krasznai A; Krajcsi P; Arányi P; Mészáros K; Horváth I
    Haematologia (Budap); 1986; 19(4):299-301. PubMed ID: 3817610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The usefulness of reactive protein C in managing patients with ulcerative colitis and Crohn's disease].
    López Morante AJ; Sáez-Royuela F; Yuguero del Moral L; Martín Lorente JL; Ojeda Giménez C
    Rev Esp Enferm Dig; 1993 Jan; 83(1):5-9. PubMed ID: 8452705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum inhibitors of leukocyte chemotaxis in Crohn's disease and ulcerative colitis.
    Rhodes JM; Potter BJ; Brown DJ; Jewell DP
    Gastroenterology; 1982 Jun; 82(6):1327-34. PubMed ID: 6978274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies on blood coagulation in ulcerative colitis and Crohn's disease].
    Mori K; Hiwatashi N; Suzuki S; Sugai K; Hisa S; Sakai H; Watanabe H; Endo K; Miura T
    Rinsho Ketsueki; 1982 Oct; 23(10):1540-8. PubMed ID: 7154258
    [No Abstract]   [Full Text] [Related]  

  • 16. Autonomic cardiovascular regulation in quiescent ulcerative colitis and Crohn's disease.
    Coruzzi P; Castiglioni P; Parati G; Brambilla V; Brambilla L; Gualerzi M; Cademartiri F; Franzè A; De Angelis G; Di Rienzo M; Di Mario F
    Eur J Clin Invest; 2007 Dec; 37(12):964-70. PubMed ID: 18036030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary excretion of N-methylhistamine as a marker of disease activity in inflammatory bowel disease.
    Winterkamp S; Weidenhiller M; Otte P; Stolper J; Schwab D; Hahn EG; Raithel M
    Am J Gastroenterol; 2002 Dec; 97(12):3071-7. PubMed ID: 12492192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum lysozyme in inflammatory bowel disease.
    Dobbins JW; Binder HJ; Spiro HM; Finch SC
    Gastroenterology; 1976 Mar; 70(3):469-71. PubMed ID: 1248707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative study of various serum proteins in patients with hemorrhagic rectocolitis and Crohn's disease].
    Loygue MJ; Sandor G; Lévy M; Malafosse M; Huguet C; Huguier M; Lévy E
    Arch Fr Mal App Dig; 1972 Oct; 61(11):649-62. PubMed ID: 4634206
    [No Abstract]   [Full Text] [Related]  

  • 20. Significance of diminished factor XIII in Crohn's disease.
    Chamouard P; Grunebaum L; Wiesel ML; Sibilia J; Coumaros G; Wittersheim C; Baumann R; Cazenave JP
    Am J Gastroenterol; 1998 Apr; 93(4):610-4. PubMed ID: 9576457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.